Amgen Inc. agreed to buy Horizon Therapeutics Plc for about $27.8 billion in its biggest-ever acquisition, outlasting at least two other suitors for the developer of autoimmune-disease treatments.
To read the entire story, you must be logged in.
Please log in now or register with us.
